UCB SA (0NZT) Gets a Buy from Barclays
In a report released today, Charles Pitman CFA from Barclays reiterated a Buy rating on UCB SA (0NZT – Research Report), with a price target of ...
BioWorld1mon
UCB/Roche lead Voyagers in Alzheimer’s tau campaign
which continues to intrigue a substantial lineup of developers. Bellwether data rolled out this fall from UCB SA and Roche AG at the Clinical Trials in Alzheimer’s Disease meeting in Madrid.
PharmiWeb13d
UCB showcases decade of growth and Patient Value Strategy driving differentiated innovation
UCB showcases decade of growth and Patient Value Strategy driving differentiated innovationBreakthrough innovation, differentiated solutions and cutting-edge pipeline to unlock growth for a decade+ ...
UCB SA (0NZT) Receives a Buy from Barclays
Barclays analyst Charles Pitman CFA maintained a Buy rating on UCB SA (0NZT – Research Report) yesterday and set a price target of €240.00. The ...